Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Euro Surveill
Main Authors: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Formato: Artigo
Idioma:Inglês
Publicado em: European Centre for Disease Prevention and Control (ECDC) 2017
Assuntos:
Surveillance and Outbreak Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://ncbi.nlm.nih.gov/pubmed/28494843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados